Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesClinical stem cell therapies for severe autoimmune diseases
Transfusion Medicine, 09/15/09
Snowden JA et al. – There is clear potential for harnessing a profound immunological effect through HSCT. However, there is a need for an ongoing balance against evolving non–transplant treatments for ADs. Ideally, these issues should be resolved in phase III studies, in which HSCT approaches are compared with the best comparator.
Related Articles
The cancer stem cell microenvironment and anti-cancer therapy
International Journal of Radiation Biology, 11/05/09
Relevance Score: 82%
Neural stem cell therapy in neurological diseases
Archives of Medical Science, 11/02/09
Relevance Score: 82%
Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation
Nephrology Dialysis Transplantation, 11/05/09
Relevance Score: 81%
Embryonic stem cell-like cells derived from adult human testis
Human Reproduction, 10/09/09
Relevance Score: 81%
Potential of cell therapy to treat pediatric motility disorders
Seminars in Pediatric Surgery, 10/01/09
Relevance Score: 81%
Today in BMT/SCT...keeping you current
Receive free subspecialty "5-minute updates" via email
Total bacterial counts on oral mucosa after using a commercial saliva substitute in patients undergoing hematopoietic cell transplantation
Supportive Care in Cancer, 12/11/09
Sirolimus for treatment of steroid-refractory acute graft-versus-host disease
Bone Marrow Transplantation, 12/11/09
The risk of early and late CMV DNAemia associated with Campath use in stem cell transplant recipients
Bone Marrow Transplantation, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor